Immunotherapy for intracranial metastatic melanoma

Objectives This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To critically appraise the safety data of immunotherapy by identifying rates of toxicities focusing on neurologic adverse events. To compare the survival outcomes of immunotherapy including progression free survival, overall survival, and clinical response rate. To appraise evidence‐based treatments for intracranial metastatic melanoma.